Journal article
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
The Lancet (British edition), Vol.391(10129), pp.1513-1523
04/14/2018
DOI: 10.1016/S0140-6736(18)30134-X
PMCID: PMC5899998
PMID: 29676281
Abstract
Background Low-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular disease.
Methods We did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose-response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12.5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5.6 years [5th-95th percentile 1.04-13.5]) from 71 011 participants from 37 studies.
Findings In the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5.4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week. Alcohol consumption was roughly linearly associated with a higher risk of stroke (HR per 100 g per week higher consumption 1.14, 95% CI, 1.10-1.17), coronary disease excluding myocardial infarction (1.06, 1.00-1.11), heart failure (1.09, 1.03-1.15), fatal hypertensive disease (1.24, 1.15-1.33); and fatal aortic aneurysm (1.15, 1.03-1.28). By contrast, increased alcohol consumption was loglinearly associated with a lower risk of myocardial infarction (HR 0.94, 0.91-0.97). In comparison to those who reported drinking >0-<= 100 g per week, those who reported drinking >100-<= 200 g per week, >200-<= 350 g per week, or >350 g per week had lower life expectancy at age 40 years of approximately 6 months, 1-2 years, or 4-5 years, respectively.
Interpretation In current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk. These data support limits for alcohol consumption that are lower than those recommended in most current guidelines. Copyright (C) The Author(s). Published by Elsevier Ltd.
Details
- Title: Subtitle
- Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
- Creators
- Angela M. Wood - University of CambridgeStephen Kaptoge - University of CambridgeAdam S. Butterworth - University of CambridgePeter Willeit - Universität InnsbruckSamantha Warnakula - University of CambridgeThomas Bolton - University of CambridgeEllie Paige - Australian National UniversityDirk S. Paul - University of CambridgeMichael Sweeting - University of CambridgeStephen Burgess - University of CambridgeSteven Bell - University of CambridgeWilliam Astle - University of CambridgeDavid Stevens - University of CambridgeAlbert Koulman - University of CambridgeRandi M. Selmer - Norwegian Institute of Public HealthW. M. Monique Verschuren - University Medical Center UtrechtShinichi Sato - Chiba Prefectural Institute of Public HealthInger NjolstadMark Woodward - The George Institute for Global HealthVeikko Salomaa - Finnish Institute for Health and WelfareBorge G. Nordestgaard - Copenhagen Univ Hosp, Copenhagen, DenmarkBu B. Yeap - Harry Perkins Institute of Medical ResearchAstrid Fletcher - London School of Hygiene & Tropical MedicineOlle Melander - Malmö UniversityLewis H. Kuller - University of PittsburghBeverley Balkau - InsermMichael Marmot - University College LondonWolfgang Koenig - German Centre for Cardiovascular ResearchEdoardo Casiglia - University of PaduaCyrus Cooper - MRC Lifecourse Epidemiology UnitVolker Arndt - German Cancer Research CenterOscar H. Franco - Erasmus MCPatrik Wennberg - Umeå UniversityJohn Gallacher - Cardiff UniversityAgustin Gomez de la Camara - Research Institute Hospital 12 de OctubreHenry Volzke - Universitätsmedizin GreifswaldChristina C. Dahm - Aarhus UniversityCaroline E. Dale - Farr InstituteManuela M. Bergmann - German Institute of Human NutritionCarlos J. Crespo - Portland State UniversityYvonne T. van der Schouw - University Medical Center UtrechtRudolf Kaaks - German Cancer Research CenterLeon A. Simons - UNSW SydneyPagona Lagiou - Hellenic Health FoundationJosje D. Schoufour - Erasmus MCJolanda M. A. Boer - National Institute for Public Health and the EnvironmentTimothy J. Key - University of OxfordBeatriz Rodriguez - University of Hawaii SystemConchi Moreno-Iribas - Instituto de Salud Pública de NavarraKarina W. Davidson - Columbia University Irving Medical CenterJames O. TaylorCarlotta Sacerdote - Città della Salute e della Scienza di Torino Hospital, Turin, Italy.Robert B. Wallace - University of IowaJ. Ramon Quiros - Gobierno del Principado de AsturiasRosario Tumino - Civic - M. Arezzo Hospital, ASP Ragusa, Italy.Dan G. Blazer - Duke UniversityAllan Linneberg - University of CopenhagenMakoto Daimon - Yamagata UniversitySalvatore Panico - Federico II University HospitalBarbara Howard - Tuskegee UniversityGuri Skeie - UiT The Arctic University of NorwayTimo Strandberg - University of HelsinkiElisabete Weiderpass - UiT The Arctic University of NorwayPaul J. Nietert - Medical University of South CarolinaBruce M. Psaty - University of WashingtonDaan Kromhout - Wageningen University & ResearchElena Salamanca-Fernandez - Instituto de Investigación Biosanitaria de GranadaStefan Kiechl - Innsbruck Medical UniversityHarlan M. Krumholz - Yale UniversitySara Grioni - Fondazione IRCCS Istituto Nazionale dei TumoriDomenico Palli - Prevention InstituteJose M. Huerta - CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.Jackie Price - University of EdinburghJohan Sundstrom - Uppsala UniversityLarraitz Arriola - Basque GovernmentHisatomi Arima - Royal Prince Alfred HospitalRuth C. Travis - University of OxfordDemosthenes B. Panagiotakos - Harokopio University of AthensAnna Karakatsani - Hellenic Health FoundationAntonia Trichopoulou - Hellenic Health FoundationTilman Kuhn - German Cancer Research CenterDiederick E. Grobbee - University Medical Center UtrechtElizabeth Barrett-Connor - University of California San DiegoNatasja van Schoor - Amsterdam Public HealthHeiner Boeing - German Institute of Human NutritionKim Overvad - Aarhus University HospitalJussi Kauhanen - University of Eastern FinlandNick Wareham - University of CambridgeClaudia Langenberg - University of CambridgeNita Forouhi - University of CambridgeMaria Wennberg - Umeå UniversityJean-Pierre Despres - Université LavalMary Cushman - University of VermontJackie A. Cooper - University College LondonCarlos J. Rodriguez - Atrium Health Wake Forest BaptistMasaru Sakurai - Kanazawa Medical UniversityJonathan E. Shaw - Baker Heart and Diabetes InstituteMatthew Knuiman - The University of Western AustraliaTrudy Voortman - Erasmus MCChrista Meisinger - Helmholtz Zentrum MünchenAnne Tjonneland - Danish Canc Soc Res Ctr, Copenhagen, DenmarkHermann Brenner - German Cancer Research CenterLuigi Palmieri - Istituto Superiore di SanitàJean Dallongeville - Institut Pasteur de LilleEric J. Brunner - University College LondonGerd Assmann - Bertelsmann FoundationMaurizio Trevisan - City College of New YorkRichard F. Gillum - Howard University HospitalIan Ford - University of GlasgowNaveed Sattar - University of GlasgowMariana Lazo - Johns Hopkins MedicineSimon G. Thompson - University of CambridgePietro Ferrari - Centre international de recherche sur le cancerDavid A. Leon - London School of Hygiene & Tropical MedicineGeorge Davey Smith - University of BristolRichard Peto - University of OxfordRod Jackson - University of AucklandEmily Banks - Australian National UniversityEmanuele Di Angelantonio - University of CambridgeJohn Danesh - University of CambridgeEmerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group
- Resource Type
- Journal article
- Publication Details
- The Lancet (British edition), Vol.391(10129), pp.1513-1523
- DOI
- 10.1016/S0140-6736(18)30134-X
- PMID
- 29676281
- PMCID
- PMC5899998
- NLM abbreviation
- Lancet
- ISSN
- 0140-6736
- eISSN
- 1474-547X
- Publisher
- Elsevier
- Number of pages
- 11
- Grant note
- LSHM_CT_2006_037197 / EU FP6 programme; European Commission European Research Council; European Research Council (ERC); European Commission British Heart Foundation U10AA025286 / NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) EPIC centres National Institute for Health Research; National Institute for Health Research (NIHR) European Union Framework 7 UK Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) HEALTH-F2-2012-279233 / European Commission Framework 7 (the EPIC-CVD award) 268834 / European Research Council; European Research Council (ERC); European Commission G0800270; MR/L003120/1 / UK Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) MR/L003120/1 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) SP/09/002; RG/08/014; RG13/13/30194 / British Heart Foundation National Institute for Health Research (National Institute for Health Research Cambridge Biomedical Research Centre)
- Language
- English
- Date published
- 04/14/2018
- Academic Unit
- Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984363638602771
Metrics
15 Record Views